Abbott India has received approval from the Central Government under Section 196 of the Companies Act, 2013 for the appointment of Kartik Rajendran (DIN: 09527717) as the Managing Director of the Company, for a period of 5 (five) years, with effect from 14 June 2025 to 13 June 2030.Powered by Capital Market - Live News

Net profit of Abbott India rose 15.80% to Rs 415.27 crore in the quarter ended September 2025 as against Rs 358.61 crore during the previous quarter ended September 2024. Sales rose 7.62% to Rs 1757.15 crore in the quarter ended September 2025 as against Rs 1632.67 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1757.151632.67 8 OPM %28.5826.89 - PBDT564.57496.94 14 PBT545.93479.43 14 NP415.27358.61 16 Powered by Capital Market - Live News

Abbott India will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News

Net profit of Abbott India rose 11.54% to Rs 365.86 crore in the quarter ended June 2025 as against Rs 328.01 crore during the previous quarter ended June 2024. Sales rose 11.60% to Rs 1738.35 crore in the quarter ended June 2025 as against Rs 1557.61 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1738.351557.61 12 OPM %25.6325.10 - PBDT512.61455.59 13 PBT493.13437.22 13 NP365.86328.01 12 Powered by Capital Market - Live News

Abbott India will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News